APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive Prenatal Testing Kit

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-Invasive Prenatal Testing Kit Market Analysis and Forecast 2026-2032

Report ID 17401761022 January 2026191 pages

Choose your research edition.

Industry ResearchNon-Invasive Prenatal Testing Kit Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive Prenatal Testing Kit Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Non-Invasive Prenatal Testing Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive Prenatal Testing Kit Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Invasive Prenatal Testing Kit Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non-Invasive Prenatal Testing Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Non-Invasive Prenatal Testing Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-Invasive Prenatal Testing Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-Invasive Prenatal Testing Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-Invasive Prenatal Testing Kit is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Non-Invasive Prenatal Testing Kit include Berry Genomics, BGI Genomics, Illumina, LabCorp, Natera, Quest Diagnostics, Sequenom and Roche, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Non-Invasive Prenatal Testing Kit, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-Invasive Prenatal Testing Kit, also provides the revenue of main regions and countries. Of the upcoming market potential for Non-Invasive Prenatal Testing Kit, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Invasive Prenatal Testing Kit revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-Invasive Prenatal Testing Kit market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Non-Invasive Prenatal Testing Kit revenue, projected growth trends, production technology, application and end-user industry.

Non-Invasive Prenatal Testing Kit Segment by Company

Berry Genomics

BGI Genomics

Illumina

LabCorp

Natera

Quest Diagnostics

Sequenom

Roche

Non-Invasive Prenatal Testing Kit Segment by Type

High & Average Risk

Low Risk

Non-Invasive Prenatal Testing Kit Segment by Application

0-12 weeks

13-24 weeks

25-36 weeks

Non-Invasive Prenatal Testing Kit Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Prenatal Testing Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Prenatal Testing Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Prenatal Testing Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Non-Invasive Prenatal Testing Kit in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Non-Invasive Prenatal Testing Kit company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Prenatal Testing Kit revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. High & Average Risk Major Player Table 3. Low Risk Major Player Table 4. Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. 0-12 weeks Major Player Table 6. 13-24 weeks Major Player Table 7. 25-36 weeks Major Player Table 8. Non-Invasive Prenatal Testing Kit Industry Trends Table 9. Non-Invasive Prenatal Testing Kit Industry Drivers Table 10. Non-Invasive Prenatal Testing Kit Industry Opportunities and Challenges Table 11. Non-Invasive Prenatal Testing Kit Industry Restraints Table 12. Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Non-Invasive Prenatal Testing Kit Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Non-Invasive Prenatal Testing Kit Market Share by Region (2021-2026) Table 15. Global Non-Invasive Prenatal Testing Kit Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Non-Invasive Prenatal Testing Kit Market Share by Region (2027-2032) Table 17. Global Non-Invasive Prenatal Testing Kit Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Players (2021-2026) Table 19. Global Non-Invasive Prenatal Testing Kit Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Non-Invasive Prenatal Testing Kit Key Players Headquarters & Area Served Table 21. Global Non-Invasive Prenatal Testing Kit Players, Product Type & Application Table 22. Global Non-Invasive Prenatal Testing Kit Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Non-Invasive Prenatal Testing Kit by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Non-Invasive Prenatal Testing Kit Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2021-2026) Table 29. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2027-2032) Table 30. Global Non-Invasive Prenatal Testing Kit Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2021-2026) Table 34. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2027-2032) Table 35. Berry Genomics Company Information Table 36. Berry Genomics Business Overview Table 37. Berry Genomics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Berry Genomics Non-Invasive Prenatal Testing Kit Product Portfolio Table 39. Berry Genomics Recent Development Table 40. BGI Genomics Company Information Table 41. BGI Genomics Business Overview Table 42. BGI Genomics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. BGI Genomics Non-Invasive Prenatal Testing Kit Product Portfolio Table 44. BGI Genomics Recent Development Table 45. Illumina Company Information Table 46. Illumina Business Overview Table 47. Illumina Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Illumina Non-Invasive Prenatal Testing Kit Product Portfolio Table 49. Illumina Recent Development Table 50. LabCorp Company Information Table 51. LabCorp Business Overview Table 52. LabCorp Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. LabCorp Non-Invasive Prenatal Testing Kit Product Portfolio Table 54. LabCorp Recent Development Table 55. Natera Company Information Table 56. Natera Business Overview Table 57. Natera Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Natera Non-Invasive Prenatal Testing Kit Product Portfolio Table 59. Natera Recent Development Table 60. Quest Diagnostics Company Information Table 61. Quest Diagnostics Business Overview Table 62. Quest Diagnostics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Quest Diagnostics Non-Invasive Prenatal Testing Kit Product Portfolio Table 64. Quest Diagnostics Recent Development Table 65. Sequenom Company Information Table 66. Sequenom Business Overview Table 67. Sequenom Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sequenom Non-Invasive Prenatal Testing Kit Product Portfolio Table 69. Sequenom Recent Development Table 70. Roche Company Information Table 71. Roche Business Overview Table 72. Roche Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Roche Non-Invasive Prenatal Testing Kit Product Portfolio Table 74. Roche Recent Development Table 75. North America Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026) & (US$ Million) Table 76. North America Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032) & (US$ Million) Table 77. North America Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Non-Invasive Prenatal Testing Kit Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Non-Invasive Prenatal Testing Kit Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Non-Invasive Prenatal Testing Kit Revenue by Country (US$ Million) & (2027-2032) Table 82. Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026) & (US$ Million) Table 83. Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032) & (US$ Million) Table 84. Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026) & (US$ Million) Table 85. Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032) & (US$ Million) Table 86. Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2021-2026) & (US$ Million) Table 88. Europe Non-Invasive Prenatal Testing Kit Revenue by Country (US$ Million) & (2027-2032) Table 89. China Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026) & (US$ Million) Table 90. China Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032) & (US$ Million) Table 91. China Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026) & (US$ Million) Table 92. China Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026) & (US$ Million) Table 94. Asia Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032) & (US$ Million) Table 95. Asia Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026) & (US$ Million) Table 96. Asia Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia Non-Invasive Prenatal Testing Kit Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Non-Invasive Prenatal Testing Kit Revenue by Region (US$ Million) & (2021-2026) Table 99. Asia Non-Invasive Prenatal Testing Kit Revenue by Region (US$ Million) & (2027-2032) Table 100. SAMEA Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026) & (US$ Million) Table 101. SAMEA Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032) & (US$ Million) Table 102. SAMEA Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026) & (US$ Million) Table 103. SAMEA Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032) & (US$ Million) Table 104. SAMEA Non-Invasive Prenatal Testing Kit Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. SAMEA Non-Invasive Prenatal Testing Kit Revenue by Country (2021-2026) & (US$ Million) Table 106. SAMEA Non-Invasive Prenatal Testing Kit Revenue by Country (US$ Million) & (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Non-Invasive Prenatal Testing Kit Image Figure 2. Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Invasive Prenatal Testing Kit Market Size Share 2021 VS 2025 VS 2032 Figure 4. High & Average Risk Image Figure 5. Low Risk Image Figure 6. Global Non-Invasive Prenatal Testing Kit Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Non-Invasive Prenatal Testing Kit Market Size Share 2021 VS 2025 VS 2032 Figure 8. 0-12 weeks Image Figure 9. 13-24 weeks Image Figure 10. 25-36 weeks Image Figure 11. Global Non-Invasive Prenatal Testing Kit Market Size (US$ Million) & (2021-2032) Figure 12. Global Non-Invasive Prenatal Testing Kit Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Non-Invasive Prenatal Testing Kit Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Non-Invasive Prenatal Testing Kit Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Non-Invasive Prenatal Testing Kit Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Non-Invasive Prenatal Testing Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2021-2032) Figure 19. Global Non-Invasive Prenatal Testing Kit Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2021-2032) Figure 22. North America Non-Invasive Prenatal Testing Kit Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032) Figure 24. North America Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032) Figure 25. North America Non-Invasive Prenatal Testing Kit Revenue Share by Country (2021-2032) Figure 26. United States Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Non-Invasive Prenatal Testing Kit Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032) Figure 31. Europe Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032) Figure 32. Europe Non-Invasive Prenatal Testing Kit Revenue Share by Country (2021-2032) Figure 33. Germany Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Non-Invasive Prenatal Testing Kit Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032) Figure 43. China Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032) Figure 44. Asia Non-Invasive Prenatal Testing Kit Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032) Figure 46. Asia Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032) Figure 47. Asia Non-Invasive Prenatal Testing Kit Revenue Share by Region (2021-2032) Figure 48. Japan Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Non-Invasive Prenatal Testing Kit Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032) Figure 56. SAMEA Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032) Figure 57. SAMEA Non-Invasive Prenatal Testing Kit Revenue Share by Country (2021-2032) Figure 58. Brazil Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Non-Invasive Prenatal Testing Kit Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • High & Average Risk
  • Low Risk
Applications
  • 0-12 weeks
  • 13-24 weeks
  • 25-36 weeks
Companies covered
  • Berry Genomics
  • BGI Genomics
  • Illumina
  • LabCorp
  • Natera
  • Quest Diagnostics
  • Sequenom
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-Invasive Prenatal Testing Kit Market by Type
  3. 1.2.1 Global Non-Invasive Prenatal Testing Kit Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 High & Average Risk
  5. 1.2.3 Low Risk
  6. 1.3 Non-Invasive Prenatal Testing Kit Market by Application
  7. 1.3.1 Global Non-Invasive Prenatal Testing Kit Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 0-12 weeks
  9. 1.3.3 13-24 weeks
  10. 1.3.4 25-36 weeks
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Non-Invasive Prenatal Testing Kit Market Dynamics
  1. 2.1 Non-Invasive Prenatal Testing Kit Industry Trends
  2. 2.2 Non-Invasive Prenatal Testing Kit Industry Drivers
  3. 2.3 Non-Invasive Prenatal Testing Kit Industry Opportunities and Challenges
  4. 2.4 Non-Invasive Prenatal Testing Kit Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Non-Invasive Prenatal Testing Kit Market Perspective (2021-2032)
  2. 3.2 Global Non-Invasive Prenatal Testing Kit Growth Trends by Region
  3. 3.2.1 Global Non-Invasive Prenatal Testing Kit Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-Invasive Prenatal Testing Kit Market Size by Region (2021-2026)
  5. 3.2.3 Global Non-Invasive Prenatal Testing Kit Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Non-Invasive Prenatal Testing Kit Revenue by Players
  2. 4.1.1 Global Non-Invasive Prenatal Testing Kit Revenue by Players (2021-2026)
  3. 4.1.2 Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Non-Invasive Prenatal Testing Kit Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-Invasive Prenatal Testing Kit Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Non-Invasive Prenatal Testing Kit Key Players Headquarters & Area Served
  7. 4.4 Global Non-Invasive Prenatal Testing Kit Players, Product Type & Application
  8. 4.5 Global Non-Invasive Prenatal Testing Kit Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Non-Invasive Prenatal Testing Kit Market CR5 and HHI
  11. 4.6.3 2025 Non-Invasive Prenatal Testing Kit Tier 1, Tier 2, and Tier 3
5 Non-Invasive Prenatal Testing Kit Market Size by Type
  1. 5.1 Global Non-Invasive Prenatal Testing Kit Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2032)
  3. 5.3 Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Type (2021-2032)
6 Non-Invasive Prenatal Testing Kit Market Size by Application
  1. 6.1 Global Non-Invasive Prenatal Testing Kit Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2032)
  3. 6.3 Global Non-Invasive Prenatal Testing Kit Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Berry Genomics
  2. 7.1.1 Berry Genomics Company Information
  3. 7.1.2 Berry Genomics Business Overview
  4. 7.1.3 Berry Genomics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Berry Genomics Non-Invasive Prenatal Testing Kit Product Portfolio
  6. 7.1.5 Berry Genomics Recent Developments
  7. 7.2 BGI Genomics
  8. 7.2.1 BGI Genomics Company Information
  9. 7.2.2 BGI Genomics Business Overview
  10. 7.2.3 BGI Genomics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BGI Genomics Non-Invasive Prenatal Testing Kit Product Portfolio
  12. 7.2.5 BGI Genomics Recent Developments
  13. 7.3 Illumina
  14. 7.3.1 Illumina Company Information
  15. 7.3.2 Illumina Business Overview
  16. 7.3.3 Illumina Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Illumina Non-Invasive Prenatal Testing Kit Product Portfolio
  18. 7.3.5 Illumina Recent Developments
  19. 7.4 LabCorp
  20. 7.4.1 LabCorp Company Information
  21. 7.4.2 LabCorp Business Overview
  22. 7.4.3 LabCorp Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  23. 7.4.4 LabCorp Non-Invasive Prenatal Testing Kit Product Portfolio
  24. 7.4.5 LabCorp Recent Developments
  25. 7.5 Natera
  26. 7.5.1 Natera Company Information
  27. 7.5.2 Natera Business Overview
  28. 7.5.3 Natera Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Natera Non-Invasive Prenatal Testing Kit Product Portfolio
  30. 7.5.5 Natera Recent Developments
  31. 7.6 Quest Diagnostics
  32. 7.6.1 Quest Diagnostics Company Information
  33. 7.6.2 Quest Diagnostics Business Overview
  34. 7.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Quest Diagnostics Non-Invasive Prenatal Testing Kit Product Portfolio
  36. 7.6.5 Quest Diagnostics Recent Developments
  37. 7.7 Sequenom
  38. 7.7.1 Sequenom Company Information
  39. 7.7.2 Sequenom Business Overview
  40. 7.7.3 Sequenom Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sequenom Non-Invasive Prenatal Testing Kit Product Portfolio
  42. 7.7.5 Sequenom Recent Developments
  43. 7.8 Roche
  44. 7.8.1 Roche Company Information
  45. 7.8.2 Roche Business Overview
  46. 7.8.3 Roche Non-Invasive Prenatal Testing Kit Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Roche Non-Invasive Prenatal Testing Kit Product Portfolio
  48. 7.8.5 Roche Recent Developments
8 North America
  1. 8.1 North America Non-Invasive Prenatal Testing Kit Revenue (2021-2032)
  2. 8.2 North America Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2032)
  3. 8.2.1 North America Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026)
  4. 8.2.2 North America Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032)
  5. 8.3 North America Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032)
  6. 8.4 North America Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2032)
  7. 8.4.1 North America Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026)
  8. 8.4.2 North America Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032)
  9. 8.5 North America Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032)
  10. 8.6 North America Non-Invasive Prenatal Testing Kit Revenue by Country
  11. 8.6.1 North America Non-Invasive Prenatal Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Non-Invasive Prenatal Testing Kit Revenue by Country (2021-2026)
  13. 8.6.3 North America Non-Invasive Prenatal Testing Kit Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Non-Invasive Prenatal Testing Kit Revenue (2021-2032)
  2. 9.2 Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2032)
  3. 9.2.1 Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026)
  4. 9.2.2 Europe Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032)
  5. 9.3 Europe Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032)
  6. 9.4 Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2032)
  7. 9.4.1 Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026)
  8. 9.4.2 Europe Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032)
  9. 9.5 Europe Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032)
  10. 9.6 Europe Non-Invasive Prenatal Testing Kit Revenue by Country
  11. 9.6.1 Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2021-2026)
  13. 9.6.3 Europe Non-Invasive Prenatal Testing Kit Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Non-Invasive Prenatal Testing Kit Revenue (2021-2032)
  2. 10.2 China Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2032)
  3. 10.2.1 China Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026)
  4. 10.2.2 China Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032)
  5. 10.3 China Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032)
  6. 10.4 China Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2032)
  7. 10.4.1 China Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026)
  8. 10.4.2 China Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032)
  9. 10.5 China Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-Invasive Prenatal Testing Kit Revenue (2021-2032)
  2. 11.2 Asia Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2032)
  3. 11.2.1 Asia Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026)
  4. 11.2.2 Asia Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032)
  5. 11.3 Asia Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032)
  6. 11.4 Asia Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2032)
  7. 11.4.1 Asia Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026)
  8. 11.4.2 Asia Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032)
  9. 11.5 Asia Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032)
  10. 11.6 Asia Non-Invasive Prenatal Testing Kit Revenue by Country
  11. 11.6.1 Asia Non-Invasive Prenatal Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Non-Invasive Prenatal Testing Kit Revenue by Country (2021-2026)
  13. 11.6.3 Asia Non-Invasive Prenatal Testing Kit Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-Invasive Prenatal Testing Kit Revenue (2021-2032)
  2. 12.2 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Type (2027-2032)
  5. 12.3 SAMEA Non-Invasive Prenatal Testing Kit Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Application (2027-2032)
  9. 12.5 SAMEA Non-Invasive Prenatal Testing Kit Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Country
  11. 12.6.1 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Non-Invasive Prenatal Testing Kit Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst